Liu Jiaxin, Xu Kaiyun, Hu Jiajie, Wang Lei, Liu Zhiyong
Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
Department of Emergence, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Curr Urol. 2025 Mar;19(2):90-94. doi: 10.1097/CU9.0000000000000273. Epub 2025 Jan 23.
Recurrent uncomplicated lower urinary tract infections (RULUTIs) are common among women without anatomical or physiological abnormalities and affect women of all age groups, races, and ethnicities. Herein, we summarized the sources of epidemiology, etiology, diagnosis, treatment, prophylaxis, and follow-up evaluations in cases of RULUTIs. Patients' medical histories, symptoms, and signs were recorded. The review showed that urinalysis, culture, and sensitivity should be tested before empiric treatment. A first-line therapeutic strategy should be applied based on the results of the urine culture and sensitivity tests. Therefore, estrogen should be used as an ancillary therapy. After the successful treatment of acute infections, intermittent or continuous prophylaxis can be administered. Patients may benefit from follow-up evaluations to avoid recurrent infections. We expect that clinicians will pay more attention to RULUTIs.
复发性单纯性下尿路感染（RULUTIs）在无解剖或生理异常的女性中很常见，影响所有年龄组、种族和民族的女性。在此，我们总结了RULUTIs病例的流行病学来源、病因、诊断、治疗、预防和随访评估。记录患者的病史、症状和体征。综述表明，在经验性治疗前应进行尿液分析、培养和药敏试验。应根据尿培养和药敏试验结果应用一线治疗策略。因此，雌激素应用作辅助治疗。急性感染成功治疗后，可进行间歇性或持续性预防。患者可能从随访评估中受益，以避免反复感染。我们期望临床医生将更多关注RULUTIs。
